Abgenix, Inc.
Biotech company reports loss of $0.48 per share
Published in Medical Device Business Week, March 30th, 2005
For the quarter ended December 31, 2004, the company reported a net loss of $42.9 million or $0.48 per share, compared to a net loss of $53.0 million or $0.60 per share for the same period in 2003.
The net loss for the fourth quarter of 2003 included a $7.9 million impairment charge related to an investment. The company ended 2004 with $416.3 million in cash, cash equivalents and marketable securities.
Revenues for the fourth quarter of 2004 were $5.9 million, compared to $6.4 million for the same period in 2003.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Abeille Pharmaceuticals, Inc.
Pharmaceutical firm completes $1M financing - Acadia Pharmaceuticals, Inc.
Pharmaceutical company reports loss of $7.3M - Advanced Neuromodulation Systems
Medical device firm reports record 4Q, 2004 neuro sales increased 36% - Akorn, Inc.
Pharmaceutical firm reports net sales of $12.6M - Albany Molecular Research, Inc.
Drug discovery firm reports 11% decrease in fourth quarter revenue - Alchemia Limited
Australian biotech firm releases half half-year results and outlook - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
